Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Edoxaban tosylate by Daiichi Sankyo for Chronic Thromboembolic Pulmonary Hypertension: Likelihood of Approval
Edoxaban tosylate is under clinical development by Daiichi Sankyo and currently in Phase III for Chronic Thromboembolic Pulmonary Hypertension. According...